Terkko Navigator / Alimentary Pharmacology & Therapeutics

Review article: prognostic significance of body composition abnormalities in patients with cirrhosis

Healthcare use, work loss and total costs in incident and prevalent Crohn's disease and ulcerative colitis: results from a nationwide study in Sweden

Factors associated with the biphasic kinetics of serum HBV RNA in patients with HBeAg‐positive chronic hepatitis B treated with nucles(t)ide analogues

Clinical assessment for high‐risk patients with non‐alcoholic fatty liver disease in primary care and diabetology practices

Sex disparities in presentation and prognosis of 1110 patients with hepatocellular carcinoma

Association between diabetes mellitus and hepatic encephalopathy in patients with liver cirrhosis

Adjustment of azathioprine dose should be based on a lower 6‐TGN target level to avoid leucopenia in NUDT15 intermediate metabolizers

Review article: chronic liver disease and pregnancy

Regular use of proton pump inhibitor and risk of rheumatoid arthritis in women: a prospective cohort study

Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus‐infected patients with renal impairment: results from a 7‐year, multicentre retrospective cohort study

Randomised clinical trial: minesapride vs placebo for irritable bowel syndrome with predominant constipation

All‐cause and cause‐specific mortality in microscopic colitis: a Danish nationwide matched cohort study

Letter: intestinal inflammation, COVID‐19 and gastrointestinal ACE2—exploring RAS inhibitors–authors’ reply

Large‐scale genome‐wide association study identifies HLA class II variants associated with chronic HBV infection: a study from Taiwan Biobank

Quality improvement project identifies factors associated with delay in IBD diagnosis

MELD remains the best predictor of mortality in outpatients with cirrhosis and severe ascites

No benefit of continuing vs stopping 5‐aminosalicylates in patients with ulcerative colitis escalated to anti‐metabolite therapy

Trace element deficiency is highly prevalent and associated with infection and mortality in patients with alcoholic hepatitis

Review article: FODMAPS, prebiotics and gut health. The FODMAP hypothesis revisited

Duration of adhesion of swallowed alginates to distal oesophageal mucosa: Implications for topical therapy of oesophageal diseases

Increasing comorbidities in a South Korea insured population‐based cohort of patients with chronic hepatitis B

Frailty is independently associated with mortality in 11 001 patients with inflammatory bowel diseases

Increased risk of permanent stoma in Crohn’s disease associated with hidradenitis suppurativa: a case‐control study

Review article: bugs, inflammation and mood—a microbiota‐based approach to psychiatric symptoms in inflammatory bowel diseases

Fibrogenesis and inflammation contribute to the pathogenesis of cirrhotic cardiomyopathy

Impact of the introduction of direct‐acting anti‐viral drugs on hepatocarcinogenesis: a prospective serial follow‐up MRI study

Real‐world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome

Randomised clinical trial: palliative long‐term abdominal drains vs large‐volume paracentesis in refractory ascites due to cirrhosis

Systematic review with meta‐analysis: efficacy and safety of treatments for opioid‐induced constipation

Systematic review with meta‐analysis: Prevalence of prior and concurrent Barrett's oesophagus in oesophageal adenocarcinoma patients

Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune‐tolerant phase

Limited added value of laboratory monitoring in thiopurine maintenance monotherapy in inflammatory bowel disease patients

English hepatitis C registry data show high response rates to directly acting anti‐virals, even if treatment is not completed

Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn’s disease patients with prior failure to anti‐TNF treatment

Reducing variation in hospital mortality for alcohol‐related liver disease in North West England

Letter: does vitamin D have a potential role against COVID‐19?

Sequential systemic treatment in patients with hepatocellular carcinoma

Systematic review with meta‐analysis: IBD‐associated colonic dysplasia prognosis in the videoendoscopic era (1990 to present)

Mortality in adults with chronic hepatitis B infection in the United States: a population‐based study

A comparative analysis of tioguanine versus low‐dose thiopurines combined with allopurinol in inflammatory bowel disease patients

Review article: the signalling and functional role of the extracellular matrix in the development of liver fibrosis

Duodenal bacterial load as determined by quantitative polymerase chain reaction in asymptomatic controls, functional gastrointestinal disorders and inflammatory bowel disease

Inflammatory bowel disease and pancreatic cancer: a Scandinavian register‐based cohort study 1969‐2017

Effectiveness of ustekinumab dose escalation in Crohn’s disease patients with insufficient response to standard‐dose subcutaneous maintenance therapy

Editorial: increasing IBD prevalence and its complications in the context of the COVID‐19 pandemic—authors' reply

Editorial: increasing IBD prevalence and its complications in the context of the COVID‐19 pandemic

Randomised clinical trial: linaclotide vs placebo—a study of bi‐directional gut and brain axis

Systematic review: medical therapy for fibrostenosing Crohn’s disease

Letter: low population mortality from COVID‐19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity

Letter: does vitamin D have a potential role against COVID‐19? Authors' reply